The genetic background and vitamin D supplementation can affect irisin levels in Prader–Willi syndrome

BACKGROUND: Prader–Willi syndrome (PWS) is associated to distinctive clinical symptoms, including obesity, cognitive and behavioral disorders, and bone impairment. Irisin is a myokine that acts on several target organs including brain adipose tissue and bone. The present study was finalized to explo...

Descripción completa

Detalles Bibliográficos
Autores principales: Faienza, M. F., Brunetti, G., Grugni, G., Fintini, D., Convertino, A., Pignataro, P., Crinò, A., Colucci, S., Grano, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421289/
https://www.ncbi.nlm.nih.gov/pubmed/33656700
http://dx.doi.org/10.1007/s40618-021-01533-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421289/
https://www.ncbi.nlm.nih.gov/pubmed/33656700
http://dx.doi.org/10.1007/s40618-021-01533-4

Ejemplares similares